Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Trial Profile

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jul 2017

At a glance

  • Drugs RVT 501 (Primary)
  • Indications Atopic dermatitis
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Dermavant Sciences
  • Most Recent Events

    • 25 Jul 2017 Status changed from active, no longer recruiting to completed.
    • 06 Jun 2017 Status changed from recruiting to active, no longer recruiting.
    • 21 Dec 2016 Status changed from not yet recruiting to recruiting, according to a Dermavant Sciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top